Skip to Main Content

Paper Details

Revolutionizing treatment of advanced melanoma with immunotherapy.
Surgical Oncology
9
2022
CTLA-4, PD-1, Programmed death receptor-1, advanced cutaneous melanoma, advanced melanoma, cytotoxic T-lymphocyte antigen-4, endocrinopathies, metastatic disease, metastatic melanoma, patients
Author NameAffiliation
Anna C PavlickNYU Perlmutter Cancer Center
  • 1 - 1

Datasets

Release 1.2